Authors: KOLARIC K BRADAMANTE V CERVEK J CIESLINSKA A CISARZFILIPCAK E DENISOV LE DONAT D DROSIK K GERSHANOVIC M HUDZIEC P JELIC S JURGA L KALASIEWICZ M KOWGIRD L KOZACKA M LICHINITZER M MACHALSKI M MECHL Z ODINTSOV S PAWLICKI M RUBACH D ROTH A STABUC B TOMCZAK J UTRACKA B ZBORZIL J ROGAN J

Citation: K. Kolaric et al., A PHASE-II TRIAL OF CARDIOPROTECTION WITH CARDIOXANE (ICRF-187) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE, Oncology, 52(3), 1995, pp. 251-255

Authors: JURGA L MISUROVA E KOVAC V SEVCIKOVA L

Citation: L. Jurga et al., THE ROLE OF CISPLATIN IN CHEMOTHERAPY OF ADVANCED BREAST-CANCER, Neoplasma, 41(6), 1994, pp. 347-352

Authors: JURGA L MISUROVA E VANCIK J

Citation: L. Jurga et al., AMELIORATION OF DOXORUBICIN CARDIOTOXICITY BY THE BISPIPERAZINEDIONE ICRF-187 IN WOMEN WITH ADVANCED BREAST-CANCER - A PRELIMINARY-REPORT, Neoplasma, 40(4), 1993, pp. 259-262